159 related articles for article (PubMed ID: 21556932)
1. Expression of GPC3 protein and its significance in lung squamous cell carcinoma.
Lin Q; Xiong LW; Pan XF; Gen JF; Bao GL; Sha HF; Feng JX; Ji CY; Chen M
Med Oncol; 2012 Jun; 29(2):663-9. PubMed ID: 21556932
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of glypican-3 (GPC3) in lung squamous cell carcinoma and lung adenocarcinoma and its clinical significance.
Yu X; Li Y; Chen SW; Shi Y; Xu F
Genet Mol Res; 2015 Aug; 14(3):10185-92. PubMed ID: 26345955
[TBL] [Abstract][Full Text] [Related]
3. GPC3 affects the prognosis of lung adenocarcinoma and lung squamous cell carcinoma.
Ning J; Jiang S; Li X; Wang Y; Deng X; Zhang Z; He L; Wang D; Jiang Y
BMC Pulm Med; 2021 Jun; 21(1):199. PubMed ID: 34112123
[TBL] [Abstract][Full Text] [Related]
4. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells.
Wei L; Sun JJ; Cui YC; Jiang SL; Wang XW; Lv LY; Xie L; Song XR
Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207
[TBL] [Abstract][Full Text] [Related]
5. The relationship between Bmi-1 and the epithelial-mesenchymal transition in lung squamous cell carcinoma.
Huang J; Qiu Y; Chen G; Huang L; He J
Med Oncol; 2012 Sep; 29(3):1606-13. PubMed ID: 21656027
[TBL] [Abstract][Full Text] [Related]
6. RBX1 expression is an unfavorable prognostic factor in patients with non-small cell lung cancer.
Xing R; Chen KB; Xuan Y; Feng C; Xue M; Zeng YC
Surg Oncol; 2016 Sep; 25(3):147-51. PubMed ID: 27566015
[TBL] [Abstract][Full Text] [Related]
7. High expression of FOXC1 is associated with poor clinical outcome in non-small cell lung cancer patients.
Wei LX; Zhou RS; Xu HF; Wang JY; Yuan MH
Tumour Biol; 2013 Apr; 34(2):941-6. PubMed ID: 23264086
[TBL] [Abstract][Full Text] [Related]
8. The role of PTPN13 in invasion and metastasis of lung squamous cell carcinoma.
Han X; Xue L; Zhou L; Gong L; Zhu S; Yao L; Wang S; Lan M; Li Y; Zhang W
Exp Mol Pathol; 2013 Dec; 95(3):270-5. PubMed ID: 23906871
[TBL] [Abstract][Full Text] [Related]
9. [Significance of glypican-3 mRNA expression in hepatocellular carcinoma tissues and peripheral blood cells].
Li BD; Zhao QC; Zhu YT; Zhang FQ; Dou KF
Zhonghua Wai Ke Za Zhi; 2006 Apr; 44(7):458-62. PubMed ID: 16772080
[TBL] [Abstract][Full Text] [Related]
10. CADM1 mRNA expression and clinicopathological significance in esophageal squamous cell carcinoma tissue.
Qian JB; Liu HB; Zhu Y; Lu F; Yang QC; Shen Y
Genet Mol Res; 2017 May; 16(2):. PubMed ID: 28510248
[TBL] [Abstract][Full Text] [Related]
11. Association between downexpression of MiR-203 and poor prognosis in non-small cell lung cancer patients.
Tang R; Zhong T; Dang Y; Zhang X; Li P; Chen G
Clin Transl Oncol; 2016 Apr; 18(4):360-8. PubMed ID: 26307752
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of Sirtuin-1 is associated with poor clinical outcome in esophageal squamous cell carcinoma.
He Z; Yi J; Jin L; Pan B; Chen L; Song H
Tumour Biol; 2016 Jun; 37(6):7139-48. PubMed ID: 26662958
[TBL] [Abstract][Full Text] [Related]
13. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
Sakai M; Kato H; Sano A; Tanaka N; Inose T; Kimura H; Sohda M; Nakajima M; Kuwano H
Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of MAC30 is associated with poor clinical outcome in human non-small-cell lung cancer.
Han KY; Gu X; Wang HR; Liu D; Lv FZ; Li JN
Tumour Biol; 2013 Apr; 34(2):821-5. PubMed ID: 23229099
[TBL] [Abstract][Full Text] [Related]
15. Abnormal hypermethylation and clinicopathological significance of Axin gene in lung cancer.
Yang LH; Xu HT; Li QC; Jiang GY; Zhang XP; Zhao HY; Xu K; Wang EH
Tumour Biol; 2013 Apr; 34(2):749-57. PubMed ID: 23192643
[TBL] [Abstract][Full Text] [Related]
16. Glypican-3 expression and its relationship with recurrence of HCC after liver transplantation.
Wang YL; Zhu ZJ; Teng DH; Yao Z; Gao W; Shen ZY
World J Gastroenterol; 2012 May; 18(19):2408-14. PubMed ID: 22654434
[TBL] [Abstract][Full Text] [Related]
17. Expression and significance of RKIP and E-cadherin in lung squamous cell carcinoma.
Zhu C; Wang Q; Xie J; Shi J; Zhou X; Li D; Xiong F; Zhang L
Pathol Oncol Res; 2013 Jan; 19(1):19-26. PubMed ID: 22692503
[TBL] [Abstract][Full Text] [Related]
18. Expression of high mobility group box - B1 (HMGB-1) and matrix metalloproteinase-9 (MMP-9) in non-small cell lung cancer (NSCLC).
Wang JL; Wu DW; Cheng ZZ; Han WZ; Xu SW; Sun NN
Asian Pac J Cancer Prev; 2014; 15(12):4865-9. PubMed ID: 24998555
[TBL] [Abstract][Full Text] [Related]
19. Molecular diagnosis and prognostic significance of lymph node micrometastasis in patients with histologically node-negative non-small cell lung cancer.
Dai CH; Li J; Yu LC; Li XQ; Shi SB; Wu JR
Tumour Biol; 2013 Apr; 34(2):1245-53. PubMed ID: 23355336
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
Qiao N; Wang L; Wang T; Li H
Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
